SCHEMBL23919269

SCHEMBL23919269

CCc1ccc2c(oc3ccccc32)c1N(c1cccc(-c2ccccc2)c1)c1ccc2ccc3c(N(c4cccc(-c5ccccc5)c4)c4c(CC)ccc5c4oc4ccccc45)ccc4ccc1c2c43

nearest known ligand 0.34

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP1B1 Q16678 1/20 0.34
ALOX5 P09917 1/20 0.33
GGPS1 O95749 1/20 0.31
ALDH1A1 P00352 2/20 0.30
KDM4E B2RXH2 1/20 0.30
HPGD P15428 1/20 0.30
HTT P42858 1/20 0.30
GLA P06280 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
PLA2G2A P14555 1/20 0.30
PLA2G4A P47712 1/20 0.30
PGR P06401 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23919275 0.92 ALOX5 (0.35) ALOX5ALDH1A1KDM4EHPGDHTT
SCHEMBL23919268 0.89 ALDH1A1 (0.37) ALOX5ALDH1A1KDM4EHPGDGLA
SCHEMBL17036263 0.87 ALOX5 (0.40) CYP1A1CYP1A2CYP1B1ALOX5GGPS1
SCHEMBL23919423 0.87 CYP1A1 (0.33) CYP1A1CYP1A2CYP1B1ALOX5ALDH1A1
SCHEMBL23919295 0.85 ALOX5 (0.31) CYP1A1CYP1A2CYP1B1ALOX5PLA2G2A
SCHEMBL23919272 0.85 ALOX5 (0.32) ALOX5ALDH1A1KDM4EHPGDHTT
SCHEMBL23849224 0.84 ALOX5 (0.33) CYP1A1CYP1A2CYP1B1ALOX5PLA2G2A
SCHEMBL23919261 0.84 CYP1A1 (0.34) CYP1A1CYP1A2CYP1B1ALOX5PLA2G2A
SCHEMBL18798581 0.83 ALOX5 (0.34) CYP1A1CYP1A2CYP1B1ALOX5GGPS1
SCHEMBL4084581 0.83 ALOX5 (0.34) CYP1A1CYP1A2CYP1B1ALOX5GGPS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320251-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE IDEMITSU KOSAN CO.,LTD. (JP) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320251-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE OLA1, TAS2R19, TMEM109 CYP1A1 1499/4885CYP1A2 1098/4885CYP1B1 2119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.